[Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D002701:Chloramphenicol / Q000494:pharmacology; D003470:Culture Media; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D007422:Intestines / Q000382:microbiology; D007709:Klebsiella / Q000187:drug effects; D002955:Leucovorin / Q000494:pharmacology; D051379:Mice; D010118:Oxytetracycline / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D011511:Proteus / Q000187:drug effects; D011743:Pyrimidines / Q000494:pharmacology*; D012486:Salmonella typhimurium / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology*
D003470:Culture Media; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D002701:Chloramphenicol; D000667:Ampicillin; D013420:Sulfamethoxazole; D010400:Penicillin G; D002955:Leucovorin; D010118:Oxytetracycline
Uber antibakterielle Eigenschaften der Kombination Trimethoprin-Sulfamethoxazol im Vergleich mit Antibiotika.